- $3.65bn
- $3.95bn
- $1.59bn
- 91
- 36
- 91
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 948 | 964 | 1,105 | 1,412 | 1,591 |
Cost of Revenue | |||||
Gross Profit | 125 | 139 | 159 | 233 | 225 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 867 | 872 | 1,026 | 1,243 | 1,426 |
Operating Profit | 80.9 | 92 | 78.7 | 169 | 165 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 92.9 | 103 | 93 | 141 | 166 |
Provision for Income Taxes | |||||
Net Income After Taxes | 71 | 78.3 | 70.9 | 105 | 121 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 70.7 | 78.3 | 70.9 | 105 | 121 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 70.7 | 78.3 | 70.9 | 105 | 121 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.27 | 1.42 | 1.67 | 2.16 | 2.44 |